Infectious Disease

Continuing education to improving adult pneumococcal immunization rates.

Meningitis is a deadly condition that affects up to 1 million people per year globally.1

A binational team of investigators at the University of California, Davis, has conducted the first comprehensive study to examine the risk factors for Rocky Mountain spotted fever in Mexicali, Mexico. They found that citywide, just 1 in 1000 ticks was infected with the disease, but in certain neighborhoods, about 1 in 10 ticks was infected.

Brown Bagging is an essential educational and safety tool for helping treat community-acquired pneumonia.

The study presented at the 29th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Amsterdam, Netherlands was a phase 2 randomized, active-controlled, double-blinded trial (N=444). All participants were ages 60 to 64 years.

A triad of techniques can reduce the likelihood of infection, and pharmacy teams can help patients with all of them.

The CDC has declared immunizations one of the greatest health achievements of the 20th century, but vaccination rates among adults remain suboptimal.

Officials with the FDA have approved Xellia Pharmaceuticals’ Premixed Vancomycin Injection in a Ready-to-Use (RTU) bag, according to the company.

HIV-positive patients with hepatocellular carcinoma had an adjusted 24% increased hazard of death compared to their HIV-negative peers.

People who inject drugs may not accurately self-report HIV and antiretroviral drug status when entering an HIV prevention study.

Community-acquired pneumonia is a major cause of mortality and morbidity among patients with HIV.

Researches seeking to eliminate HIV are close enough to see the finish line, but with no idea how far away they are from a cure.

Foreign-born black women aren’t benefiting from HIV prevention programs at the same rates as other women.

The overuse of antimicrobials is associated with antimicrobial resistance, which is now a global crisis.

New research underscores the value of review by an ID physician, nurse, or pharmacist before starting OPAT.

The product has an estimated market size of $338M for the 12 months ending August 2018 according to IQVIA.

Stigma may cause undiagnosed individuals with HIV to go unidentified and fail to get quality care and treatment.

FDA officials have approved omadacycline (Nuzyra, Paratek), a modernized tetracycline, to treat adults with acute skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP).

Inconsistency of insurance policy coverage, unaffordability, and difficulty accessing vaccine providers were found to be key barriers for adult immunization in a recent study by UCLA Center for Health Policy researchers.

Financial modeling tool shows research and development lacking of new vaccine candidates for HIV, tuberculosis, and malaria.

Community-acquired pneumonia is a common infection and a leading cause of morbidity and mortality worldwide.

Watch as our Executive Vice President for Pharmacy Advocacy discusses pharmacy roles in immunizations, and record his "word of the day" for a chance to win $1000 gift card!

Staying up to date with vaccinations is crucial in preventing children and their classmates from getting sick.

Although it can lead to death, PCP is preventable with appropriate prophylaxis therapy given to patients at high risk of infection.

Approval for tafenoquine was granted based on the efficacy and safety data gleaned from a comprehensive global clinical development program for P vivax prevention of relapse,

Antimicrobial stewardship programs (ASPs) are often tasked with addressing a wide scope of antimicrobial misuse with limited resources.

Testing for respiratory syncytial virus (RSV) infection during the influenza season is uncommon among pregnant mothers.

Top news of the day from across the health care landscape